Kala Pharmaceuticals, Inc. reported raising $67.9 Million in an initial SEC Form D filing, from an offering of $67.9 Million
Amount Raised
$67.9 Million
Round Type
Venture
ArlingtonBiotechnologyHealth CareTherapeuticsQuick answer
KALA BIO, Inc. raised $67.9 Million in a funding round, dated April 13, 2016. KALA BIO, Inc. is based in Arlington, Massachusetts, United States.
- How much did KALA BIO, Inc. raise?
- KALA BIO, Inc. raised $67.9 Million in a funding round on April 13, 2016.
- What does KALA BIO, Inc. do?
- Kala Pharmaceuticals develops novel treatments for diseases that affect mucosal tissues.
- Where is KALA BIO, Inc. based and how big is it?
- KALA BIO, Inc. is based in Arlington, Massachusetts, United States. Fundz records about 38 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as KALA BIO, Inc. that raised within 45 days of this round, from Fundz verified event records.
- CytoDyn raised $4.3M (Seed) on May 11, 2016.
- G1 Therapeutics, Inc. raised $47M on May 11, 2016.
- TuHURA Biosciences raised $5.6M on May 10, 2016.
- AbbVie Inc. raised $3.8B on May 9, 2016.
- Madrigal Pharmaceuticals raised $3.4M (Seed) on April 28, 2016.
- Alpha Cognition raised $385K (Seed) on April 26, 2016.
Who to call at KALA BIO, Inc., and when
A new round usually means KALA BIO, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day KALA BIO, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at KALA BIO, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at KALA BIO, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment KALA BIO, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
KALA BIO, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.